Molecular basis of restenosis and drug-eluting stents.
Costa
Marco A
MA
Division of Cardiology & Cardiovascular Imaging Core Laboratories, University of Florida, Shands-Jacksonville, Jacksonville, Fla, USA.
Simon
Daniel I
DI
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D049109:Cell Proliferation; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000473:pathology; D006083:Graft Occlusion, Vascular / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications / Q000473:pathology; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D004364:Pharmaceutical Preparations